This is a long term play with upside only after 2024-2025 with clinical trials and China entry. The big risk might be DNA based solutions in the 10 year+ timeframe taking away some of the perceived upside.
Ann: Appendix 4C and Business Activity Report - Dec-22 Qtr, page-11
Add VTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.010(6.25%) |
Mkt cap ! $9.356M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.0¢ | $3.194K | 19.15K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8000 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 88579 | 2 |
View Market Depth
| Last trade - 14.09pm 03/06/2024 (20 minute delay) ? |
| VTI (ASX) Chart |